Faron Pharmaceuticals narrows loss as cancer treatment trials continue
(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday posted an improvement in half-year results with "strong and steady progress" for its immunotherapy programme. Read More
Price | 185.00p on 17-09-2025 | at 18:30:06
---|---|
Change | -2.50p -1.33% |
Buy | 190.00p |
Sell | 180.00p |
Last Trade: | Buy 525.00 at 187.90p |
Day's Volume: | 8,255 |
Last Close: | 185.00p |
Open: | 187.50p |
ISIN: | FI4000153309 |
Day's Range | 185.00p - 187.50p |
52wk Range: | 142.50p - 265.00p |
Market Capitalisation: | £207.12m |
VWAP: | 184.7283p |
Shares in Issue: | 111.95m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Faron Pharmaceuticals (FARN) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 525 | 187.90p | Ordinary |
16:27:13 - 17-Sep-25 |
Buy* | 400 | 187.90p | Ordinary |
12:53:13 - 17-Sep-25 |
Buy* | 1,060 | 187.90p | Ordinary |
12:17:52 - 17-Sep-25 |
Sell* | 119 | 183.05p | Ordinary |
10:47:58 - 17-Sep-25 |
Buy* | 2 | 195.00p | SI Trade |
09:33:28 - 17-Sep-25 |
Buy* | 25 | 195.00p | SI Trade |
09:33:28 - 17-Sep-25 |
Sell* | 30 | 180.00p | SI Trade |
09:33:28 - 17-Sep-25 |
Sell* | 5,000 | 183.00p | Ordinary |
09:33:07 - 17-Sep-25 |
Sell* | 500 | 183.05p | Ordinary |
08:55:03 - 17-Sep-25 |
Sell* | 71 | 183.05p | Ordinary |
08:04:24 - 17-Sep-25 |
Faron Pharmaceuticals (FARN) Regulatory News |
||
Date | Source | Headline |
---|---|---|
3rd Mar 2025 12:05 pm | RNS | FDA Grants Orphan Drug Designation |
28th Feb 2025 12:00 pm | RNS | Notice of Annual General Meeting |
27th Feb 2025 7:30 am | RNS | Positive EMA Opinion on Orphan Drug Designation |
27th Feb 2025 7:15 am | RNS | Annual Report 2024 published |
27th Feb 2025 7:00 am | RNS | Financial Statement 1 January to 31 December 2024 |
19th Feb 2025 10:00 am | RNS | Notice of Financial Statement and Annual Report |
14th Feb 2025 12:00 pm | RNS | Holding(s) in Company |
11th Feb 2025 7:30 am | RNS | Change of Broker |
6th Feb 2025 3:00 pm | RNS | Holding(s) in Company |
6th Feb 2025 7:00 am | RNS | Results of Oversubscribed Placing |